Change in the microbiota of bronchial tree in children with bronchial asthma from past to our days

1. Астафьева НГ, Кобзев ДЮ, Гамова ИВ и соавт. Роль микробиома дыхательных путей в респираторном здоровье. Лечащий врач. 2019; 5: 88–92. [Astaf’eva NG, Kobzev DYu, Gamova IV i soavt. Rol’ mikrobioma dykhatel’nykh putei v respiratornom zdorov’e. Lechashchii vrach. 2019; 5: 88–92. (In Russ).]

2. Федосенко СВ, Огородова ЛМ, Карнаушкина МА и соавт. Состав сообщества микроорганизмов в дыхательных путях у здоровых лиц и больных бронхиальной астмой. Вестник РАМН. 2014; 3–4: 71–76. [Fedosenko SV, Ogorodova LM, Karnaushkina MA i soavt. Sostav soobshchestva mikroorganizmov v dykhatel’nykh putyakh u zdorovykh lits i bol’nykh bronkhial’noi astmoi. Vestnik RAMN. 2014; 3–4: 71–76. (In Russ).]

3. Man WH, Steenhuijsen Piters WA de, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol. 2017; 15(5): 259–270. doi: 10.1038/nrmicro.2017.14.

4. Tsoi LC, Yang J, Liang Y et al. Lower airway microbiota and mycobiota in children with severe asthma J Allergy Clin Immunol. 2018; 141(2): 808–811. doi.org/10.1016/j.jaci.2017.07.054

5. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010; Jan 5; 5(1): e8578. doi: 10.1371/journal.pone.0008578.

6. Sokolowska M., Frei R., Lunjani N. et al. Microbiome and asthma. Asthma Res Pract. 2018; Jan 5; 4: 1. doi: 10.1186/s40733-017-0037-y.

7. Huang YJ, Nariya S, Harris JM et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol. 2015; 136: 874–884. doi: 10.1016/j.jaci.2015.05.044.

8. Carr TF, Alkatib R, Kraft M. Microbiome in Mechanisms of Asthma. Clin Chest Med. 2019; Mar; 40 (1): 87–96. doi: 10.1016/j.ccm.2018.10.006.

9. Рыбакова ОГ, Федоров ИА. Диагностика бронхиальной астмы у детей раннего возраста. Доктор.ру. 2019; 9(164): 43–45. [Rybakova OG, Fedorov IA. Diagnostika bronkhial’noi astmy u detei rannego vozrasta. Doktor.ru. 2019; 9(164): 43–45. (In Russ).] doi: 10.31550/1727-2378-2019-164-9-43-45.

10. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology. 2006; 11(1): 54–61. doi: 10.1111/j.1440-1843.2006.00784.x.

11. Федоров ИА, Пушкарева ЮЭ, Рыбакова ОГ. Микробиота респираторного тракта у детей при тяжелой бронхиальной астме. Доктор.ру. 2018; 11(155): 57–60. [Fedorov IA, Pushkareva YuEh, Rybakova OG. Mikrobiota respiratornogo trakta u detei pri tyazheloi bronkhial’noi astme. Doktor.ru. 2018; 11(155): 57–60. (In Russ).]. doi: 10.31550/1727-2378-2018-155-11-57-60.

12. Jacobs MC, Lankelma JM, Wolff NS et al. Effect of antibiotic gut microbiota disruption on LPS-induced acute lung inflammation. PLoS One. 2020; Nov 4; 15(11): e0241748. doi: 10.1371/journal.pone.0241748.

13. Zhang L, Forst CV, Gordon A et al. Characterization of antibiotic resistance and host-microbiome interactions in the human upper respiratory tract during influenza infection. Microbiome. 2020; Mar 17; 8(1): 39. doi: 10.1186/s40168-020-00803-2.

14. Celebi Sözener Z, Cevhertas L, Nadeau K et al. Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020; Jun; 145(6): 1517–1528. doi: 10.1016/j.jaci.2020.04.024.

15. Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021; Nov; 21(11): 739–751. doi: 10.1038/s41577-021-00538-7.